NYSE:RCUS

Arcus Biosciences Stock Predictions

etoro logo Buy RCUS
*Your capital is at risk
$23.86
-0.610 (-2.49%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RCUS Prediction Chart

RCUS Predictions History

Latest community submissions for RCUS.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 11, 2025 $25.88 +1.96% $25.16 X 97.15% 0
Dec 11, 2025 $25.69 +1.23% $25.16 X 97.89% 0
Dec 11, 2025 Bullish $25.16 X 0
Nov 26, 2025 $23.79 -2.03% $25.56 X 93.06% 0
Nov 26, 2025 $23.97 -1.27% $25.56 X 93.78% 0
Nov 26, 2025 $46.54 +100.78% Unrealistic Excluded from avg $25.56 V 17.92% 1
Nov 25, 2025 $22.71 -2.02% $24.28 X 93.55% 0
Nov 25, 2025 $22.89 -1.26% $24.28 X 94.27% 0
Nov 25, 2025 Bullish $24.28 V 1
Oct 30, 2025 $19.81 -2.37% $20.19 V 98.11% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RCUS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ARCUS BIOSCIENCES INC.
Arcus Biosciences
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Pha...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE